您的位置: 首页 > 农业专利 > 详情页

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
专利权人:
VERTEX PHARMACEUTICALS INCORPORATED
发明人:
BINCH, HAYLEY,FANNING, LEV, T
申请号:
NZ59268509
公开号:
NZ592685A
申请日:
2009.10.23
申请国别(地区):
NZ
年份:
2013
代理人:
摘要:
592685 Disclosed is a compound of formula (I) which is an azabicyclic substituted on a phenyl group which in turn is substituted on a dihydroquinoline. Examples of compounds of formula (I) are: N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2- (trifluoromethyl)phenyl)-4-oxo-5-( trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide; N-(4-(7-azabicydo[2.2.1]heptan-7-yl)-2-cyanophenyl)-5-methyl-4-oxo-1,4-dihydroquinoline-3-carboxamide and N-[4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(3-dimethylaminoprop-1-ynyl)phenyl]-4-oxo-5-(trifluoromethyl)-1H -quinoline-3-carboxamide. Also disclosed are pharmaceutical compositions and kits comprising a compound of formula (I) Further disclosed is the use of a compound of formula (I) in the manufacture of a medicament for the treatment of diseases such as cystic fibrosis, COPD, liver diseases and Alzheimer's disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充